The results showed that the expression of CTSG, MMP9, PRTN3, RETN, RNASE2, and RNASE3 were dramatically upregulated in CML-CP comparing to the normal cells (P < 0.001). Here, PRTN3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.